Antlia Bioscience

Developer of peptide-based therapeutic solutions for the treatment of chronic heart failure

placeSan Diego, California, United States calendar_todayFounded 2020 groups3 employees language antliabio.com

Registered entities

Innovation

2 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 11 times.

YearFilings
20221
20231
20241
20252

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%
Coming soon